NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Amgen Inc


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Amarin Corp Is First Small Biopharmaceutical Company to Join SAFE-BioPharma Association
2009 NOV 23 ... The Association's members include: Abbott (NYSE: ABT) Amarin (NASDAQ: AMRN) Amgen (NASDAQ: AMGN) AstraZeneca (NYSE: AZN) Bristol-Myers Squibb (NYSE: BMY) GlaxoSmithKline ... Merck (NYSE: MRK) National Notary Association Novartis Pfizer (NYSE: PFE) Premier Inc. Roche Sanofi-Aventis (NYSE: SNY) ScheringPlough-Organon (NYSE: SGP) SNAP Diagnostics ...
Subject: SAFE-BioPharma Association
Price: $3.00
*
American Heart Association Late-breaking Clinical Trial Report: Risks of Anemia Drug Outweigh Benefits in Cardiovascular Disease Patients With Diabetes and Kidney Disease
2009 NOV 30 ... benefits." The research was supported and conducted in collaboration with Amgen. Co-authors are: Emmanuel A. Burdmann, M.D., Ph.D.; Chao-Yin Chen, Ph.D.; ...
Subject: American Heart Association
Price: $3.00
*
Amgen to Present at 18th Annual Credit Suisse Healthcare Conference
2009 NOV 23 ... are available on Amgen's Investor Relations Events Calendar. Keywords: , Amgen Inc., Pharmaceutical Business, Pharmaceutical Company. This article was ...
Subject: Amgen
Price: $3.00
*
Amgen to Present at Lazard Capital Healthcare Conference
2009 NOV 30 ... are available on Amgen's Investor Relations Events Calendar. Keywords: Amgen Inc., Pharmaceutical Business, Pharmaceutical Company. This article was ...
Subject: Amgen
Price: $3.00
*
BCIU Hosts Central, Eastern European Competitiveness Forum in Vienna for Global Entrepreneurship Week 2009
2009 NOV 30 ... Investing, Investment, Investment Company, Oil & Gas, Politics, Technology, World Bank, Amgen Inc., Business Council for International Understanding, Pharmaceutical Business, ...
Subject: Business Council for International Understanding
Price: $3.00
*
CellCyte Genetics Corp. Announces the Appointment of Douglas P. Cerretti, Ph.D. as Chief Science Officer and Director of Business Development
2009 NOV 23 ... Health, Biotechnology, Genetics, Pharmaceutical, Research, Science, Technology, Amgen Inc., Biopharmaceuticals, Biotechnology Business, Biotechnology Company, Drug Development, ...
Subject: CellCyte Genetics Corporation
Price: $3.00
*
Colorado Bioscience Association Recognizes the Best of Colorado's Bioscience Industry
2009 NOV 16 ... of the Series A financing to $12 million. The company also engaged three new investors, Amgen Ventures, Broadview Ventures and The Peierls Foundation, who join founding investors ... which is on the cutting edge of bioscience education. She is also a co-founder of Myogen Inc., a highly successful CU spin-out that was acquired by Gilead for $70 million. Following ...
Subject: Colorado BioScience Association
Price: $3.00
*
Critical Alerts for GE, Amgen, Nike, Green Mountain Coffee Roasters, and Coeur d'Alene Mines Released by Seven Summits Research
2009 NOV 23 ... Today's PriceWatch Alerts cover the following stocks: General Electric Co. (NYSE:GE), Amgen Inc. (NASDAQ:AMGN), Nike Inc. (NYSE:NKE), Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR), ...
Subject: Seven Summits Investment Research
Price: $3.00
*
First-of-its-Kind Collaboration Among Advocacy Groups Provides Lung Cancer Patients Personalized Information About Clinical Trials
2009 NOV 30 ... support for the Lung Cancer Clinical Trial Call to Action campaign and matching service: Amgen Inc., AstraZeneca, Genentech BioOncology, and Pfizer Oncology. Keywords: ...
Subject: Boehringer Ingelheim
Price: $3.00
*
Heartbeat Digital to Speak at FDA Hearing
2009 NOV 23 ... healthcare and luxury industries. The agency's healthcare clients include Amgen, Auxilium, Bayer, Becton Dickinson, Cephalon, Endo Pharmaceuticals, Life Line Screening, ...
Subject: Heartbeat Digital
Price: $3.00
*
ImmunoGen, Inc. Announces Election of Howard Pien to its Board of Directors and Other Results from its Annual Meeting of Shareholders
2009 NOV 23 ... Genentech and Roche. Other ImmunoGen collaborative partners include Bayer HealthCare and Amgen. More information about ImmunoGen can be found at www.immunogen.com. ... ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products, ...
Subject: ImmunoGen, Inc.
Price: $3.00
*
Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints
2009 NOV 16 ... will be included in labeling once discussions are complete. Keywords: Amgen Inc., Anemia, Aranesp, Blood Transfusion, Cardiology, Cardiovascular, Chronic Kidney ...
Subject: Anemia
Price: $3.00
*
Ninety Eight Percent of Surveyed Rheumatologists Will Prescribe Roche's Actemra for Rheumatoid Arthritis
2009 NOV 16 ... regarding clinical, economic and scientific factors. Keywords: Adalimumab, Amgen Inc., Arthritis, Biologics, Biotechnology, Clinical Trial Research, Drugs, Enbrel, ...
Subject: Arthritis
Price: $3.00
*
Pipeline Insight: Colorectal Cancer - Growing Trend towards Personalized Medicine
2009 NOV 23 ... Key companies involved in the colorectal cancer (CRC) pipeline Amgen AstraZeneca Roche Key R&D company strategies ...
Subject: Research and Markets
Price: $3.00
*
Prescribing Options for Treating Inflammation Positioned to Benefit from an Active Drug Pipeline
2009 NOV 16 ... Source: Greystone Associates Keywords: Aging, Amgen Inc., Biotechnology, Cimzia, Drug Development, Drugs, Enzymes, FDA, Inflammation, Kinase, ...
Subject: Inflammation
Price: $3.00
*
Research reports from Amgen, Inc. provide new insights into proteomics
2009 NOV 16 ... 2009;81(20):8354-8364). For additional information, contact Z.Q. Zhang, Amgen Inc., Processing & Prod Development, M-S 30E-1-B, 1 Amgen Center Dr., Thousand Oaks, CA ...
Subject: Proteomics
View Free
Daily News
Article
Research results from Amgen, Inc. update understanding of bone marrow
2009 NOV 23 ... Additional information can be obtained by contacting C.A. Gabel, Amgen Inc., Inflammat Department, 1201 Amgen Court W, Mailstop 2262, Seattle, WA 98119, USA. ...
Subject: Bone Marrow
View Free
Daily News
Article
Stelara is Expected to Substantially Alter Patient Flow to TNF-Alpha Inhibitors Prescribed for Psoriasis Over the Next Two Years
2009 NOV 23 ... are the leading reasons for its use ahead of Humira. Keywords: Adalimumab, Amgen Inc., Biotechnology Business, Biotechnology Company, Centocor Inc., Corticosteroid, ...
Subject: Psoriasis
Price: $3.00
*
Sucampo Pharmaceuticals Reports Financial Results for the Third Quarter of 2009
2009 NOV 16 ... the university in 2005, Mr. Ashton held a number of senior executive positions at Amgen Inc., including Business Unit Vice President/General Manager of Corporate Accounts and Vice ...
Subject: Sucampo Pharmaceuticals, Inc.
Price: $3.00
*
Trubion Pharmaceuticals, Inc. Announces Transition in Company Leadership
2009 NOV 30 ... purchase by American Cyanamid Co. and remained a member of the board until 1997. Amgen Inc. acquired Immunex in 2002. Additional Management Appointments ...
Subject: Trubion Pharmaceuticals, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login